跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,089 条关于
“steatohepatitis”
全部
1,089
临床试验
685
药物
22
机构
7
资讯
375
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
去年
NASH Treatment Market to Reach Significant Growth by 2032, Driven by Emerging Therapies
去年
AI-Based Pathology Tool Validated for Scoring Metabolic Dysfunction-Associated Steatohepatitis
2年前
FDA Approves Rezdiffra (Resmetirom) as First Treatment for NASH with Liver Fibrosis
去年
Semaglutide 2.4mg Demonstrates Superior Improvement in MASH and Liver Fibrosis in Phase 3 Trial
去年
Semaglutide Shows Promise in Phase III MASH Trial, Comparable to Rezdiffra
去年
Semaglutide 2.4 mg Shows Promise in Phase 3 ESSENCE Trial for MASH Treatment
去年
Semaglutide 2.4 mg Shows Promise in Treating MASH and Liver Fibrosis
去年
Semaglutide Shows Promise in Phase III Trial for Liver Fibrosis and MASH
去年
Semaglutide 2.4 mg Shows Promise in MASH Treatment: Phase 3 ESSENCE Trial Results
第 1 页,共 38 页
上一页
下一页